NASDAQ:LMOS (LMOS) (LMOS) Stock Price, News & Analysis → Altcoin FRENZY Alert… (From Crypto 101 Media) (Ad) Free LMOS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$17.98▼$17.9850-Day Range N/A52-Week Range$14.02▼$17.99VolumeN/AAverage Volume232,861 shsMarket CapitalizationN/AP/E Ratio25.69Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (LMOS) alerts: Email Address Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About (LMOS) Stock (NASDAQ:LMOS)Lumos Networks Corp. is a fiber-based bandwidth infrastructure and service provider in the Mid-Atlantic region with a network of long-haul fiber, metro Ethernet and Ethernet rings located primarily in Virginia and West Virginia, and portions of Maryland, Pennsylvania, Ohio and Kentucky. The Company serves carrier, business and residential customers over its fiber network offering data, voice and Internet protocol (IP) services. The Company operates through three segments: Data, Residential and Small Business (R&SB), and RLEC Access. The Data segment includes the Company's enterprise data, transport and Fiber to the Cell (FTTC) product groups. The R&SB segment includes voice and IP services products targeted to its residential and small business customers. The RLEC Access segment provides other carrier customers access to the Company's network within the Company's rural local exchange carrier (RLEC) territories through switched access services.Read More Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. LMOS Stock News HeadlinesMarch 4, 2024 | msn.comRwanda: Inside Rwanda's Biosafety Law Set to Regulate GMOsMarch 3, 2024 | msn.comInside Rwanda's biosafety law set to regulate GMOsMarch 28, 2024 | DTI (Ad)How you can target big results without spending big money!While most folks are paying $500… $1,000… Or even MORE to trade popular stocks like Apple, Nvidia, or Microsoft… I’ve discovered a new way to tap into what could be the cheapest options on the market… I’m talking about the $0.25 Cent Trades! February 28, 2024 | msn.comRwanda finally passes law on GMO: What next?February 28, 2024 | msn.comSix things to know as Rwanda promulgates GMO lawFebruary 27, 2024 | msn.comRwanda Finally Passes Law On GMO - What Next?February 27, 2024 | msn.comRwanda finally passes law on GMOs: What next?January 2, 2024 | forbes.comA Public Year For Private Jet Flight ProvidersMarch 28, 2024 | WealthPress (Ad)A lot of people are making this costly mistakeYou may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. December 24, 2023 | msn.com108 stores open on Christmas Eve 2023 for last-minute shoppingDecember 20, 2023 | msn.comDouble-digit number of candidates set to challenge Putin in Russian electionDecember 12, 2023 | msn.comThese major retailers went out of business in 2023July 26, 2023 | msn.comWhat’s the Biodiversity (Amendment) Bill passed by Lok Sabha & why it is facing criticismJuly 16, 2023 | msn.comRwanda introduces new biosafety bill to regulate GMOsMarch 30, 2023 | msn.comDelhi CM to review Covid-19 preparation today, health minister asks people not to panicMarch 30, 2023 | msn.comDelhi govt closely watching COVID-19 situation; Kejriwal's review meeting on FridayFebruary 21, 2023 | msn.comArsenal: Arteta made 'harsh decision' on £180k-a-week star at the EmiratesFebruary 6, 2023 | msn.comRwanda's Green Growth Vs GMO Preparing for Better or Worse [opinion]February 6, 2023 | msn.comRwanda’s green growth vs GMO preparing for better or worseJanuary 26, 2023 | msn.comWho is Gerard Pique’s new girlfriend Clara Chia as they go Instagram official?January 12, 2023 | msn.comScientists push for GMO seeds as pests threaten cropsNovember 6, 2022 | msn.comRyusei Yamanaka tops Moto3 timesheet in Valencia practiceNovember 5, 2022 | msn.comQuartararo proud of title defence whatever happens in MotoGP finaleOctober 25, 2022 | msn.comRoad closures: four for Nottingham drivers this weekOctober 10, 2022 | msn.comMother and baby may have lain dead for days after apparent murder-suicideOctober 9, 2022 | msn.com15 Thoughts Saw Something on SaturdayAugust 17, 2022 | msn.comAtiku, Wike’s men hold peace talks on FridaySee More Headlines Receive LMOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (LMOS) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/08/2016Today3/28/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryAlternative Carriers Current SymbolNASDAQ:LMOS CUSIP55028310 CIK1520744 Webwww.lumosnetworks.com Phone+1-540-9462000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio25.69 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesRobert E. Guth (Age 52)Independent Chairman of the Board Timothy G. Biltz (Age 57)President, Chief Executive Officer, Director Johan G. BroekhuysenChief Financial Officer, Executive Vice President, Chief Accounting OfficerJoseph E. McCourt Jr. (Age 54)Executive Vice President, Chief Revenue Officer Thomas E. FerrySenior Vice President, Chief Technology OfficerDiego B. Anderson (Age 47)Senior Vice President, General Manager - Residential and Small Business William G. Davis Jr. (Age 43)Senior Vice President, Marketing & Investor Relations and Chief of Staff Mary McDermott (Age 61)Senior Vice President - Legal and Regulatory Affairs, Secretary Jeffrey J. Miller (Age 53)Senior Vice President - Business Development Josh WolffSenior Vice President - Lumos Data Center BusinessMore Executives LMOS Stock Analysis - Frequently Asked Questions How were (LMOS)'s earnings last quarter? (LMOS) (NASDAQ:LMOS) released its quarterly earnings results on Tuesday, November, 8th. The utilities provider reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.01. The utilities provider had revenue of $51.80 million for the quarter, compared to analysts' expectations of $52.66 million. The business's quarterly revenue was up 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.06 EPS. What other stocks do shareholders of (LMOS) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (LMOS) investors own include AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Cara Therapeutics (CARA), Fate Therapeutics (FATE), LivePerson (LPSN), Telaria (TLRA), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF) and Adicet Bio (ACET). This page (NASDAQ:LMOS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research Advisory Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (LMOS) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.